It is well documented that the PI3K/Akt/mTOR and TGF-β/Smad signaling pathways are becoming increasingly difficult to ignore in investigations of EMT-related mechanisms in cancer cells [40,41,42,43]. This evidence concerns the gene AKT1 and cancer.